D-0455-2017 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0455-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 12, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jun 29, 2018). Affected quantity: 8,537 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 8, 2017
Initiation Date
Jan 12, 2017
Termination Date
Jun 29, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,537 bottles

Product description

Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat, India.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

a) JKP5530A Exp. 12/17, JKP3991A Exp. 11/17, JKR6535A Exp. 07/18 b) JKP5529A Exp. 11/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0455-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0455-2017. Report a data issue: hello@regdatalab.com.